= Solution
\b[In 1865 <Mercury> was the principal systemic remedy for early constitutional <syphilis>, while <potassium iodide> was especially associated with later destructive lesions; neither is an acceptable substitute for modern <penicillin> therapy.] Historical classifications depended chiefly on clinical appearance, before identification of <Treponema pallidum> and modern <serology>.
For a primary indurated <chancre>, period treatment combined cleanliness, protection from friction and irritant discharges, and, in mercurial practice, a prolonged course of a <Mercury> preparation. Administration could be by mouth or by rubbing an ointment into the <skin>; some practitioners used fumigation. Local cauterisation of a sore could not be assumed to remove infection already spread beyond it. Painful soft sores and suppurating groin swellings were often discussed among venereal diseases, but modern <chancroid> is distinct from <syphilis>; an 1865 “variety” cannot automatically be assigned the same cause or treatment.<Health of the Navy: Home Station report (1864)>[discussion of infecting sores, soft sores, buboes, mercurial and non-mercurial practice]{ref}
In secondary disease, with generalised eruptions and mucosal lesions, <Mercury> was used in carefully watched courses, with food, hygiene and local care. Blue pill, grey powder and other mercurial compounds were alternative forms, not interchangeable quantities. Stomatitis, excessive salivation, bowel disturbance and constitutional deterioration were reasons to interrupt treatment, not desirable signs of cure. Relapse after apparent healing was recognised. For later <gummatous syphilis>, painful periosteal swellings, ulceration and some nervous manifestations, <potassium iodide>, sometimes combined with a mercurial, was a characteristic period choice. Apparent symptomatic improvement did not demonstrate eradication of the <infection>.<Remarks on Syphilis and Its Treatment (1864)>[pp. 17–23, secondary disease, mercurial effects and uncertainty]{ref}<Clinical Commentaries on late syphilis in the British Medical Journal (1864)>[3 September, p. 263, late tertiary lesions and iodide practice]{ref}
Congenital disease also received mercurial treatment in the period, together with attention to feeding and the mother. That history must be separated from present management: <congenital syphilis> results from maternal <infection>, not an inherited constitutional taint. Maternal treatment, infant examination and laboratory evaluation determine modern management; an affected infant can require a full course of parenteral <penicillin> even without obvious external lesions.<Congenital Syphilis treatment guidance by CDC>[evaluation and scenario-specific regimens]{ref}
Modern early acquired <syphilis>, including primary, secondary and early latent disease, is ordinarily treated with \b[benzathine <penicillin G>, 2.4 million units intramuscularly once] in adults. Late latent disease or disease of unknown duration ordinarily requires \b[three weekly 2.4-million-unit injections]. <Neurosyphilis>, ocular disease and otic disease require a regimen with appropriate tissue penetration, ordinarily \b[aqueous crystalline <penicillin G>, 18–24 million units per day intravenously for 10–14 days], rather than the single early-disease injection. Pregnancy, allergy, congenital disease and other special circumstances need the corresponding specialist pathway. Clinical and quantitative <serology>[serological] follow-up, partner management and assessment for coexisting <infections> are part of treatment. The stage labels guide management, but nervous, ocular or auditory involvement can occur at more than one stage.<Primary and Secondary Syphilis treatment guidance by CDC>[recommended adult regimen]{ref}<Latent Syphilis treatment guidance by CDC>[early and late latent regimens]{ref}<Neurosyphilis, Ocular Syphilis, and Otosyphilis treatment guidance by CDC>[recommended regimen and ocular/otic management]{ref}
Back to article page
